title: Central venous access ports in children treated for hematopoietic malignancies.
abstract: During past 10 years 234 central venous access ports (CVAP) were implanted in 225 patients at the Department of Pediatric Hematology and Oncology in Zabrze. Mean exposure time was 745 days and total implantation time reached 173,768 days. Complications were encountered in 17 patients (7.6%). This mainly concerned central venous line infection, which led to removal of 10 CVAP (4.4%). The remaining complications necessitating removal of the CVAP consisted mainly of mechanical problems (catheter fracture, occlusion, and erroneous implantation to artery). In the opinion of the authors, subcutaneously implanted CVAP are a safe and effective option for high-dose chemotherapy deliverance in childhood cancer patients.
authors.affiliation: Department of Emergency Medicine, Bytom, Medical University of Silesia, Katowice, Poland.
authors.forename: Bogusław
authors.initials: B
authors.lastname: Bucki
authors.forename: Renata
authors.initials: R
authors.lastname: Tomaszewska
authors.forename: Jacek
authors.initials: J
authors.lastname: Karpe
authors.forename: Piotr
authors.initials: P
authors.lastname: Stoksik
authors.forename: Danuta
authors.initials: D
authors.lastname: Sońta-Jakimczyk
authors.forename: Tomasz
authors.initials: T
authors.lastname: Szczepański
mesh_terms: D000293:Adolescent; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007239:Infections / Q000209:etiology*; D008297:Male